BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 10071342)

  • 21. Genome-wide array-based comparative genomic hybridization of natural killer cell lymphoma/leukemia: different genomic alteration patterns of aggressive NK-cell leukemia and extranodal Nk/T-cell lymphoma, nasal type.
    Nakashima Y; Tagawa H; Suzuki R; Karnan S; Karube K; Ohshima K; Muta K; Nawata H; Morishima Y; Nakamura S; Seto M
    Genes Chromosomes Cancer; 2005 Nov; 44(3):247-55. PubMed ID: 16049916
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical relevance of three subtypes of primary sinonasal lymphoma characterized by immunophenotypic analysis.
    Kim GE; Koom WS; Yang WI; Lee SW; Keum KC; Lee CG; Suh CO; Hahn JS; Roh JK; Kim JH
    Head Neck; 2004 Jul; 26(7):584-93. PubMed ID: 15229900
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of interleukin-9 in nasal natural killer/T-cell lymphoma cell lines and patients.
    Nagato T; Kobayashi H; Kishibe K; Takahara M; Ogino T; Ishii H; Oikawa K; Aoki N; Sato K; Kimura S; Shimizu N; Tateno M; Harabuchi Y
    Clin Cancer Res; 2005 Dec; 11(23):8250-7. PubMed ID: 16322282
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary ocular natural killer/T-cell lymphomas: clinicopathologic features and diagnosis.
    Yang Y; Luo Q; He W; Tang L
    Ophthalmologica; 2007; 221(3):173-9. PubMed ID: 17440279
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lethal Epstein-Barr virus associated NK/T-cell lymphoma with primary manifestation in the conjunctiva.
    Widmer S; Tinguely M; Egli F; Thiel MA
    Klin Monbl Augenheilkd; 2005 Mar; 222(3):255-7. PubMed ID: 15785994
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Natural killer cell neoplasms.
    Liang X; Graham DK
    Cancer; 2008 Apr; 112(7):1425-36. PubMed ID: 18286525
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Understanding the group of peripheral T-cell lymphomas, unspecified.
    Zucca E; Zinzani PL
    Curr Hematol Rep; 2005 Jan; 4(1):23-30. PubMed ID: 15610656
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fine-needle aspiration cytology of extranodal natural killer/T-cell lymphoma.
    Jiménez-Heffernan JA; González-Peramato P; Perna C; Alvarez-Ferreira J; López-Ferrer P; Viguer JM
    Diagn Cytopathol; 2002 Dec; 27(6):371-4. PubMed ID: 12451569
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD30 positive (non-anaplastic) peripheral T-cell lymphoma of the thyroid gland.
    Forconi F; Bocchia M; Marconcini S; Bigazzi C; Milani M; Fraternali-Orcioni G; Lauria F
    Haematologica; 1999 Oct; 84(10):946-8. PubMed ID: 10509044
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extranodal nasal type NK/T-cell lymphoma: elucidating clinical prognostic factors for risk-based stratification of therapy.
    Lee J; Park YH; Kim WS; Lee SS; Ryoo BY; Yang SH; Park KW; Kang JH; Park JO; Lee SH; Kim K; Jung CW; Park YS; Im YH; Kang WK; Lee MH; Ko YH; Ahn YC; Park K
    Eur J Cancer; 2005 Jul; 41(10):1402-8. PubMed ID: 15963893
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Retrospective analysis of 304 cases of malignant lymphomas in pathology: study and practice of the WHO classification of lymphoid neoplasms].
    Yin HF; Li T; Li JX
    Zhonghua Yi Xue Za Zhi; 2003 Sep; 83(18):1556-60. PubMed ID: 14642107
    [TBL] [Abstract][Full Text] [Related]  

  • 32. International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes.
    Vose J; Armitage J; Weisenburger D;
    J Clin Oncol; 2008 Sep; 26(25):4124-30. PubMed ID: 18626005
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytotoxic protein expression in non-Hodgkin's lymphomas and Hodgkin's disease.
    Kanavaros P; Vlychou M; Stefanaki K; Rontogianni D; Gaulard P; Pantelidaki E; Zois M; Darivianaki K; Georgoulias V; Boulland ML; Gorgoulis V; Kittas C
    Anticancer Res; 1999; 19(2A):1209-16. PubMed ID: 10368677
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extranodal NK/T-cell lymphoma: diagnosis and treatment cues.
    Suzuki R; Takeuchi K; Ohshima K; Nakamura S
    Hematol Oncol; 2008 Jun; 26(2):66-72. PubMed ID: 18283711
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serous effusions in malignant lymphomas: a review.
    Das DK
    Diagn Cytopathol; 2006 May; 34(5):335-47. PubMed ID: 16604559
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathobiology of mature T-cell lymphomas.
    Cotta CV; Hsi ED
    Clin Lymphoma Myeloma; 2008 Dec; 8 Suppl 5():S168-79. PubMed ID: 19073524
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peripheral T-cell and NK-cell lymphomas and their mimics; taking a step forward - report on the lymphoma workshop of the XVIth meeting of the European Association for Haematopathology and the Society for Hematopathology.
    Attygalle AD; Cabeçadas J; Gaulard P; Jaffe ES; de Jong D; Ko YH; Said J; Klapper W
    Histopathology; 2014 Jan; 64(2):171-99. PubMed ID: 24128129
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peripheral T-cell and NK-cell lymphomas in the WHO classification: pearls and pitfalls.
    Jaffe ES; Nicolae A; Pittaluga S
    Mod Pathol; 2013 Jan; 26 Suppl 1(Suppl 1):S71-87. PubMed ID: 23281437
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathobiology of T-cell and NK-cell lymphomas.
    Bajor-Dattilo EB; Pittaluga S; Jaffe ES
    Best Pract Res Clin Haematol; 2013 Mar; 26(1):75-87. PubMed ID: 23768642
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Questions on diagnosis and treatment of peripheral T/NK cell lymphomas].
    Zhu J
    Zhonghua Nei Ke Za Zhi; 2009 Mar; 48(3):177-8. PubMed ID: 19576079
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.